IL22RA1 and metabolic dysfunction-associated steatotic liver disease: Modulation of the IL-22-IL-22R axis seems to be an ideal therapeutic strategy for NAFLD, considering its multiple functions, such as antioxidative, antiapoptotic and proregenerative effects, by activating STAT3 cascades in hepatocytes (Table 1).